Skip to main content

IMMUTEP Ltd

IMMP
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001506184

No open-market purchases or sales by IMMUTEP Ltd insiders were filed in the last 90 days; 25 institutions reported holding it in 13F filings for Q2 2026, worth $692.0K in total; no superinvestor holds it.

Other share classesPRRUF

Q4 2023 vs. Q3 2023

How the institutions holding IMMUTEP Ltd changed between Q3 2023 and Q4 2023.

All holders in Q4 2023All holders in Q3 2023

13F holders of IMMP: Q3 2023 compared with Q4 2023
MeasureQ3 2023Q4 2023Change
Holders2123+2
Shares1.94M2.04M+106.8K (+5.5%)
Value$3.68M$4.90M+$1.22M (+33.3%)

New holders (9)

Institutions that held IMMUTEP Ltd at the end of Q4 2023 but not at the end of Q3 2023.

Institutions new to IMMP in Q4 2023
InstitutionSharesValue% of portfolio
BlackRock Inc.646,228$1.55M0.00%
Caption Management, LLC73,292$175.9K0.02%
Jane Street Group, LLC52,468$125.9K0.00%
Simplex Trading, LLC28,385$68.0K0.00%
GTS Securities LLC24,596$59.0K0.00%
Virtu Financial LLC12,198$29.0K0.00%
Group One Trading, L.P.3,652$8.77K0.00%
Royal Bank of Canada66$00.00%
Ronald Blue Trust, Inc.196$00.00%

Sold out (7)

Institutions that held IMMUTEP Ltd at the end of Q3 2023 and filed for Q4 2023 without it.

Institutions that sold out of IMMP in Q4 2023
InstitutionShares, Q3 2023Value, Q3 2023
Integrated Advisors Network LLC13,000$24.7K
HighTower Advisors, LLC12,001$23.0K
LPL Financial LLC10,650$20.2K
Citadel Advisors LLC4,332$8.23K
Qube Research & Technologies Ltd183$348
JPMorgan Chase & Co2$4
Hantz Financial Services, Inc.10$0